What is NDC 71357-013?

71357-013 is the product NDC for Dihydroergotamine Mesylate, Dihydroergotamine mesylate 1 mg/mL injection, solution, listed with the FDA by Milla Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Milla Pharmaceuticals Inc., NDC labeler code 71357. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dihydroergotamine Mesylate?

10 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dihydroergotamine Mesylate NDC 71357-013

NDC codes

FDA NDC Directory

Product NDC (as listed)71357-013Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71357-0013Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71357-013-05	7135700130571357001305	5 AMPULE in 1 CARTON (71357-013-05) / 1 mL in 1 AMPULE (71357-013-01)Marketed from May 22, 2026
71357-013-10	7135700131071357001310	10 AMPULE in 1 CARTON (71357-013-10) / 1 mL in 1 AMPULE (71357-013-01)Marketed from May 22, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dihydroergotamine Mesylate
Generic name (nonproprietary): dihydroergotamine mesylate
Active ingredients: Dihydroergotamine mesylate — 1 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous, Subcutaneous
Labeler: Milla Pharmaceuticals Inc.NDC labeler code 71357
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212046
Marketing start: Sep 30, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Ergotamines (Chemical structure)
Identifiers: Product ID 71357-013_52ba951e-772f-ca73-e063-6294a90a5fd1SPL ID 52ba951e-772f-ca73-e063-6294a90a5fd1SPL set ID b464a64d-b150-4f6b-b3df-e486a41294d7RxCUI 861672UNII 81AXN7R2QT
Pharmacologic class: Ergotamine Derivative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471357001305 followed by a unit qualifier and the quantity

Package 71357-0013-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 26, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dihydroergotamine Mesylate Injection, USP is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71357-013

What is NDC 71357-013?: 71357-013 is the product NDC for Dihydroergotamine Mesylate, Dihydroergotamine mesylate 1 mg/mL injection, solution, listed with the FDA by Milla Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dihydroergotamine Mesylate.
What is the active ingredient?: Dihydroergotamine mesylate.
Who is the labeler?: Milla Pharmaceuticals Inc., NDC labeler code 71357. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dihydroergotamine Mesylate?: 10 other product NDCs are listed under this name. See all Dihydroergotamine Mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dihydroergotamine Mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 4 mg/mL	Spray, MeteredNasal	Somerset Therapeutics, LLC	70069-880	70069-0880-08
Dihydroergotamine mesylate	Dihydroergotamine mesylate 4 mg/mL	SprayNasal	Trifluent Pharma, LLC	73352-096	73352-0096-19
dihydroergotamine mesylate	Dihydroergotamine mesylate 1 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Baxter Healthcare Corporation	36000-300	36000-0300-10
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Gland Pharma Limited	68083-466	68083-0466-10
Dihydroergotamine mesylate	Dihydroergotamine mesylate 4 mg/mL	SprayNasal	Advagen Pharma Ltd	72888-096	72888-0096-1972888-0096-34
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9151	00143-9151-10
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 1 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Provepharm Inc.	81284-411	81284-0411-0581284-0411-10
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 4 mg/mL	SprayNasal	Hikma Pharmaceuticals USA Inc.	24201-463	24201-0463-08
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9273	00143-9273-10
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 4 mg/mL	SprayNasal	Oceanside Pharmaceuticals	68682-357	68682-0357-10

Other NDCs under ANDA 212046

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212046
Product	Strength	Form · route	Labeler	Product NDC
Dihydroergotamine Mesylate	Dihydroergotamine mesylate 1 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Provepharm Inc.	81284-411